ImmunoGen drug fails cancer study, shares slide 40 percent - Reuters https://t.co/ell3otLLHI
— Discovery Institute (@discoverynj) March 1, 2019
from Twitter https://twitter.com/discoverynj
March 01, 2019 at 04:18AM
Friday, March 1, 2019
ImmunoGen drug fails cancer study, shares slide 40 percent - Reuters https://t.co/ell3otLLHI
from Twitter https://twitter.com/discoverynj
March 01, 2019 at 04:18AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment